Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Loprinzi

Showing results (1-10 of 302) with videos related to

Pageof 31
Sort By:
Current Oncology Reports|May 27, 2004
Hot flash trial ICharles L Loprinzi
Current Oncology Reports|September 10, 2008
Minocycline for preventing EGFR inhibitor-induced rashCharles L Loprinzi
Current Oncology Reports|June 11, 2005
Recombinant human erythropoietin and overall survivalCharles L Loprinzi
Current Oncology Reports|May 27, 2004
Hot flash trial IICharles L Loprinzi
Current Oncology Reports|May 27, 2004
Hot flash trial IIICharles L Loprinzi
Current Oncology Reports|February 3, 2007
Denosumab in postmenopausal women with low bone mineral densityCharles L Loprinzi
ACP Journal Club|March 17, 2006
900 mg daily of gabapentin was effective for hot flashes in women with breast cancerCharles L Loprinzi
The Journal of Supportive Oncology|September 9, 2004
New therapeutic approaches for hot flashes in womenVered Stearns, Charles L Loprinzi
Clinical Journal of Oncology Nursing|February 27, 2004
Making sense of the evidence regarding nonhormonal treatments for hot flashesDebra Barton, Charles L Loprinzi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Adenosine triphosphate: does it help cancer patients "get bigger and stronger"?Aminah Jatoi, Charles L Loprinzi
Pageof 31

Showing results (1-10 of 302) with videos related to

Sort By:
Pageof 31
Current Oncology Reports|May 27, 2004
Hot flash trial ICharles L Loprinzi
Current Oncology Reports|September 10, 2008
Minocycline for preventing EGFR inhibitor-induced rashCharles L Loprinzi
Current Oncology Reports|June 11, 2005
Recombinant human erythropoietin and overall survivalCharles L Loprinzi
Current Oncology Reports|May 27, 2004
Hot flash trial IICharles L Loprinzi
Current Oncology Reports|May 27, 2004
Hot flash trial IIICharles L Loprinzi
Current Oncology Reports|February 3, 2007
Denosumab in postmenopausal women with low bone mineral densityCharles L Loprinzi
ACP Journal Club|March 17, 2006
900 mg daily of gabapentin was effective for hot flashes in women with breast cancerCharles L Loprinzi
The Journal of Supportive Oncology|September 9, 2004
New therapeutic approaches for hot flashes in womenVered Stearns, Charles L Loprinzi
Clinical Journal of Oncology Nursing|February 27, 2004
Making sense of the evidence regarding nonhormonal treatments for hot flashesDebra Barton, Charles L Loprinzi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Adenosine triphosphate: does it help cancer patients "get bigger and stronger"?Aminah Jatoi, Charles L Loprinzi
Pageof 31